Highlights Genentech Announces FDA Approval of Xofluza for the Treatment of Acute, Uncomplicated Influenza in People 12 Years of Age and Older Seqirus Receives FDA Approval of Afluria® Quadrivalent (Influenza Vaccine) for People Six Months of Age and Older in…
Highlights National HPV Roundtable Hosts Webinar on New HPV-9 Indication – October 29, 3PM Eastern NFID hosts Webinar on Pneumococcal Vaccines: Strategies to Increase Adult Immunization Rates – October 30 at Noon ET New 65+ Flu Defense Website Features Tools…